Correlation Engine 2.0
Clear Search sequence regions

filter terms:
Sizes of these terms reflect their relevance to your search.

The CLIP1-LTK fusion drives advanced non-small cell lung cancer (NSCLC) and represents a therapeutic target. ©2022 American Association for Cancer Research.


The CLIP1-LTK Fusion Is an Oncogenic Driver of NSCLC. Cancer discovery. 2022 Feb;12(2):286

PMID: 34893497

View Full Text